Search Results - "Mora‐Peris, B"
-
1
Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV‐infected subjects
Published in Journal of the International AIDS Society (01-11-2012)“…Background Once‐daily nucleoside‐sparing combination antiretroviral therapy (cART) regimens, such as maraviroc/darunavir/ritonavir, may be attractive…”
Get full text
Journal Article -
2
Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones
Published in Journal of antimicrobial chemotherapy (01-02-2001)“…The genes encoding topoisomerases (gyrA and grlA) and the norA promoter of 100 fluoroquinolone-susceptible and -resistant Staphylococcus aureus clinical…”
Get full text
Journal Article -
3
Raltegravir resistance in the cerebrospinal fluid
Published in Infection (01-06-2013)“…We report the first published case of integrase inhibitor resistance in the central nervous system compartment in the absence of evidence of integrase…”
Get full text
Journal Article -
4
In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum
Published in International journal of antimicrobial agents (01-11-2003)“…The in vitro activity of ciprofloxacin, erythromycin, telithromycin, teicoplanin, linezolid and quinupristin-dalfopristin was tested against human derived…”
Get full text
Journal Article -
5
Neurological focus in a female patient with systemic lupus erythematosus
Published in Revista clínica espanõla (01-06-2009)Get more information
Journal Article -
6
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy
Published in Journal of antimicrobial chemotherapy (01-06-2014)“…Objectives Pharmacokinetic parameters following modifications to antiretroviral therapy and sanctuary site exposure are often unknown for recently licensed…”
Get full text
Journal Article -
7
Implicación de los genes "ermX" en la resistencia a los macrólidos y la telitromicina de "Corynebacterium jeikeium" y "Corynebacterium amycolatum"
Published in Revista española de quimioterapia (01-09-2005)“…Se ha estudiado la actividad de siete macrólidos, clindamicina y telitromicina frente a aislamientos clínicos del género Corynebacterium. De éstos, 36…”
Get full text
Journal Article -
8
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
Published in Journal of antimicrobial chemotherapy (01-06-2013)“…Once-daily nucleoside-sparing combination antiretroviral therapy regimens are attractive options for the treatment of HIV infection. However, the…”
Get full text
Journal Article -
9
In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacteriumurealyticum
Published in International journal of antimicrobial agents (2003)“…The in vitro activity of ciprofloxacin, erythromycin, telithromycin, teicoplanin, linezolid and quinupristin–dalfopristin was tested against human derived…”
Get full text
Journal Article -
10
Implication of ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum
Published in Revista española de quimioterapia (01-09-2005)“…The activity of seven macrolides, clindamycin and telithromycin against clinical isolates of Corynebacterium spp. was studied. Of these, 36 isolates were…”
Get full text
Journal Article -
11
Hemorrhagic cystitis caused by BK and JC polyomavirus in patients treated with bone marrow transplantation: clinical features and urologic management
Published in Actas urologicas españolas (01-02-2002)“…Differential diagnosis of hematuria after bone marrow transplantation (B.M.T.) may include polyomavirus (BK and JC)-associated haemorrhagic cystitis. Many…”
Get more information
Journal Article -
12
Activity of new quinolones against clinical isolates of Corynebacterium species
Published in Revista española de quimioterapia (01-09-2000)“…The activity of six quinolones (ciprofloxacin, levofloxacin, trovafloxacin, moxifloxacin, clinafloxacin and grepafloxacin) against 86 clinical isolates of…”
Get full text
Journal Article